ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Radiation Oncology

Top Radiation Oncology Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LANNIS HALL

Radiation Oncology

781

$37.6K

159
142 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 15%

$48
Average prescription price

Avg: $37

ROBERT JOHNSON MD

Radiation Oncology

731

$24.2K

153
128 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 15%

$33
Average prescription price

Avg: $37

MARY GRAHAM MD

Radiation Oncology

629

$38.9K

110
82 are 65+

20%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 15%

$62
Average prescription price

Avg: $37

DAVID BUTLER M.D.

Radiation Oncology

596

$24.4K

146
130 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 11%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 15%

$41
Average prescription price

Avg: $37

JOHN SHELDON MD

Radiation Oncology

508

$14.6K

110
99 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 15%

$29
Average prescription price

Avg: $37

ROBERT FRAZIER M.D.

Radiation Oncology

447

$16.3K

86
66 are 65+

20%
patients receiving schedule two controlled substances

Avg: 9%

23%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 15%

$36
Average prescription price

Avg: $37

IBRAHIM ABDALLA M.D.

Radiation Oncology

441

$10.6K

126
109 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

21%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 15%

$24
Average prescription price

Avg: $37

ROGER GOOD M.D.

Radiation Oncology

417

$15.8K

68
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 15%

$38
Average prescription price

Avg: $37

JOHN BEDWINEK MD

Radiation Oncology

397

$9,721

91
77 are 65+

31%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 15%

$24
Average prescription price

Avg: $37

HUMBERTO FAGUNDES MD

Radiation Oncology

364

$13.1K

110
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 15%

$36
Average prescription price

Avg: $37

MARK THOMPSON M.D.

Radiation Oncology

363

$18.4K

120
102 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 15%

$51
Average prescription price

Avg: $37

MICHAEL ALBRITTON MD

Radiation Oncology

320

$8,573

96
77 are 65+

18%
patients receiving schedule two controlled substances

Avg: 9%

25%
patients receiving schedule three controlled substances

Avg: 11%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 15%

$27
Average prescription price

Avg: $37

DANIEL KELETI M.D.

Radiation Oncology

295

$5,612

69
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

32%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 15%

$19
Average prescription price

Avg: $37

PERRY GRIGSBY MD

Radiation Oncology

295

$5,727

70
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 15%

$19
Average prescription price

Avg: $37

MICHAEL BEAT M.D.

Radiation Oncology

290

$12.4K

94
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 15%

$43
Average prescription price

Avg: $37

KENON QAMAR M.D.

Radiation Oncology

280

$6,310

81
72 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

30%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 15%

$23
Average prescription price

Avg: $37

SCOTT COZAD MD

Radiation Oncology

278

$12.4K

99
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

18%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 15%

$45
Average prescription price

Avg: $37

JAY ROBINOW MD

Radiation Oncology

250

$9,490

98
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 15%

$38
Average prescription price

Avg: $37

JEFF MICHALSKI MD

Radiation Oncology

179

$7,580

56
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 15%

$42
Average prescription price

Avg: $37

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank